Zimmermann Martineinsider trades
In SEC Form 4 filings, Zimmermann Martine is listed as Director of Ligand Pharmaceuticals Inc (LGND) and Director of Candel Therapeutics, Inc. (CADL). In the last 90 days, Zimmermann Martine sold $342K of Ligand Pharmaceuticals Inc (LGND) on the open market and bought none.
Companies and roles
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-10
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| LGNDLigand Pharmaceuticals Inc | Sep 22 | Sep 24 | F | 115 | $298.50 | $34,328 | 3,782 | No | Form 4 |
| LGNDLigand Pharmaceuticals Inc | Sep 10 | Sep 14 | S | 1,200 | $285.00 | Sale −$342,000 | 3,897 | No | Form 4 |
| CADLCandel Therapeutics, Inc. | Sep 8 | Sep 10 | A · derivative | 64,000 | $12.60 | $806,400 | 64,000 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.